Search results
Results from the WOW.Com Content Network
Marijuana has been an illegal Schedule I drug since 1970, but re-scheduling it to be a Schedule III drug could have a limited effect on cannabis consumers, although some cannabis businesses have ...
In a move that could significantly impact the cannabis reform landscape, the Drug Enforcement Administration (DEA) announced a delay on Monday in the rescheduling of marijuana, noting it would ...
DEA lawsuit NO. 20-71433, the Ninth Circuit dismissed a petition that asked the court to review the DEA's denial of a letter that requested the agency reschedule marijuana. Under the CSA, the DEA must begin investigating the rescheduling of a drug after receiving a petition by from any interested party, including the manufacturer of a drug, a ...
Marijuana has been a Schedule I drug since the Controlled Substances Act was signed in 1970. This bureaucratic move is only a small step toward what advocates hope will be full legalization of the ...
The Single Convention is the main international treaty related to Cannabis sativa L. and its products.In its Article 1, the Single Convention defines "cannabis" as the "flowering or fruiting tops of the cannabis plant (excluding the seeds and leaves when not accompanied by the tops) from which the resin has not been extracted, by whatever name they may be designated;" while "cannabis resin" is ...
DEA began the program in 1979 during the War on Drugs. In the first few years of the Reagan administration , the program expanded from seven states to forty. [ 1 ] By 1985 it was active in all fifty states.
The federal government first classified cannabis as a Schedule I drug back in 1970 with the Controlled Substances Act. For years, it sat alongside heroin on the same list under federal law.
Hemp Industries Association v. Drug Enforcement Administration, often shortened to HIA v. DEA, refers to two lawsuits concerning the legality of cannabis extracts and other products from the hemp plant that have very low or nonexistent natural THC levels, including CBD oil, in the United States. The first is from 2004 and the second is from 2018.